TEVA

PACLITAXEL PROTEIN-BOUND PARTICLES

Manufacturer:

TEVA

Paclitaxel Protein-Bound Particles HCPCS:

J9258

HCPCS Code Descriptor:

Injection, paclitaxel protein-bound particles (teva) not therapeutically equivalent to j9264, 1 mg

Category:

J Code

Paclitaxel Protein-Bound Particles NDCs:

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Paclitaxel Protein-Bound Particles:

PACLITAXEL PROTEIN-BOUND PARTICLES is a Oncology drug manufactured by TEVA and administered via the route of administration. The J Code: J9258 is aligned to the drug PACLITAXEL PROTEIN-BOUND PARTICLES.

ACCESS PRICING AND MORE BY REGISTERING

J9258 Added Date:

January 1, 2024

J9258 Effective Date:

January 1, 2024

J9258 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Paclitaxel Protein-Bound Particles billing and coding information.
Our team did not identify a source for Paclitaxel Protein-Bound Particles patient assistance information. Please reach out to our team if you feel that this is a mistake.
PACLITAXEL PROTEIN-BOUND PARTICLES prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PACLITAXEL PROTEIN-BOUND PARTICLES. Please check back in a few weeks.